CO[C@@H](C)[C@](O)(C(=O)OC1=CCN2CC[C@H](O)[C@H]12)C(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?